Distribution spectrum of paraoxonase activity in HDL fractions.
about
Apolipoprotein J: A New Predictor and Therapeutic Target in Cardiovascular Disease?Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function.Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairmentEffects of dietary components on high-density lipoprotein measures in a cohort of 1,566 participants.HDL-3 is a superior predictor of carotid artery disease in a case-control cohort of 1725 participants.Associations between PON1 enzyme activities in human ovarian follicular fluid and serum specimens.Effect of vitamin e and selenium supplement on paraoxonase-1 activity, oxidized low density lipoprotein and antioxidant defense in diabetic ratsHDL and endothelial protection.A randomised controlled trial of increasing fruit and vegetable intake and how this influences the carotenoid concentration and activities of PON-1 and LCAT in HDL from subjects with type 2 diabetes.Frequency distribution of the single-nucleotide -108C/T polymorphism at the promoter region of the PON1 gene in Asian Indians and its relationship with coronary artery disease.A review of paraoxonase 1 properties and diagnostic applications.HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies.Effect of cyclosporine-a on paraoxonase activity in wistar rats.The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status.Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome.Downregulation of paraoxonase 3 contributes to aggressive human hepatocellular carcinoma progression and associates with poor prognosis.The age-related paraoxonase 1 response is altered by long-term caloric restriction in male and female rats.Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients.Rosuvastatin Decreases the Formation of Neointima by Increasing Apo J, Reducing Restenosis after Balloon Injury in Rats
P2860
Q26781196-D5EBBA88-9B11-4C4C-9CBD-120594D629E1Q33752486-5E0749A0-7AFA-43EA-9706-5BF1AB99BEF6Q33878870-A67CCE63-7001-4F87-A961-6ADBB4AFC247Q34253260-4C7843DF-EFDA-48E0-873F-3D1CC07ABA50Q35021827-5B4447FC-7589-4CC2-89F2-1750D306CE0EQ36280030-69EB9958-DFBE-48AE-B453-450AC1735B5FQ36829311-99B8DF2A-8C07-4A4F-BAC4-2F1A3739EF11Q36929420-39D89AD5-8CF9-44C2-9168-20DEB0BB78E3Q37502297-48661409-9954-488B-BBA5-332EA26F035CQ38618215-5935BD63-828D-4B82-B6E0-D7D04892DE3DQ38812792-D19B1BD5-391D-4F63-AF2C-7EB5931DE280Q38955607-596CEF45-E4E6-4B84-8AF6-F2962AAAC5E8Q42727210-894F76A0-40C9-43A0-A0EE-2C3106B84B19Q46581280-F40572D9-07EE-43C6-8D71-E12E5A8B90D2Q51316398-00026756-A08C-4C69-A19D-80F001555879Q51555277-396DAE7B-69C1-4820-AA19-C2264423FFDBQ51797321-0092479B-800E-4570-BE26-2923864FC96AQ53080484-987AB87D-AB79-40F9-ABEB-3AF56869A0BCQ58588691-4C55C32C-0671-42CD-AD8E-4E466B1D5E72
P2860
Distribution spectrum of paraoxonase activity in HDL fractions.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Distribution spectrum of paraoxonase activity in HDL fractions.
@ast
Distribution spectrum of paraoxonase activity in HDL fractions.
@en
Distribution spectrum of paraoxonase activity in HDL fractions.
@nl
type
label
Distribution spectrum of paraoxonase activity in HDL fractions.
@ast
Distribution spectrum of paraoxonase activity in HDL fractions.
@en
Distribution spectrum of paraoxonase activity in HDL fractions.
@nl
prefLabel
Distribution spectrum of paraoxonase activity in HDL fractions.
@ast
Distribution spectrum of paraoxonase activity in HDL fractions.
@en
Distribution spectrum of paraoxonase activity in HDL fractions.
@nl
P2093
P1433
P1476
Distribution spectrum of paraoxonase activity in HDL fractions.
@en
P2093
Christoph Bergmeier
Rüdiger Siekmeier
Werner Gross
P304
P356
10.1373/CLINCHEM.2004.034439
P407
P577
2004-09-30T00:00:00Z